Jiandong Xu
Chief Financial Officer · Estrella Immunopharma, Inc.
IndividualBuying only
- 2026
- Aug 26, 2026
- 2
Filings (90d)
Other insiders active in the same sector
No other insider has filed at Jiandong Xu's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- BAKER BROS. ADVISORS LP - $172.50M in KYMR purchases and sales in the last 12 months
- Keith S. Manchester - $154.47M in ROIV purchases and sales in the last 12 months
- QVT Financial LP - $147.38M in ROIV purchases and sales in the last 12 months
- Daniel Allen Gold - $147.38M in ROIV purchases and sales in the last 12 months
- ULSE Inc. - $146.25M in ULS purchases and sales in the last 12 months
- Michael Benkowitz - $135.23M in UTHR purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Jiandong Xu?
Jiandong Xu is a corporate insider, tracked as Chief Financial Officer of Estrella Immunopharma, Inc. (ESLA). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Jiandong Xu submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Jiandong Xu been buying or selling stock?
Recorded transactions: 3 open-market purchases ($3K) and 0 open-market sales across all tracked filings.
